Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

25d ago

CYCC

PremiumPress Releases

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

1M ago

CYCC

PremiumPre-Earnings

Is CYCC a Buy, Before Earnings?

1M ago

CYCC

PremiumPress Releases

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

1M ago

CYCC

PremiumPress Releases

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

2M ago

CYCC

PremiumPress Releases

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

2M ago

CYCC

PremiumPress Releases

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

2M ago

CYCC

More CYCC News >

CYCC News on the Web

2024-04-25

Cyclacel Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future

Yahoo Finance

Neutral

2024-04-01

Is Cyclacel Pharmaceuticals Inc (CYCC) Stock at the Top of the Biotechnology Industry?

Investors Observer

Neutral

2024-04-01

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

Yahoo Finance

Neutral

2024-03-27

Cyclacel Pharmaceuticals Inc (CYCC) Stock: What Does the Chart Say Wednesday?

Investors Observer

Neutral

2024-03-20

Cyclacel Pharmaceuticals, Inc. Q4 2023 Earnings Call Transcript

Yahoo Finance

Neutral

2024-03-20

CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023

InvestorPlace

Neutral

2024-03-19

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Yahoo Finance

Neutral

2024-03-13

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

CYCC

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CYCC’s Media Buzz Sentiment?

1 articles about CYCC were published this week. In an average week, 1 articles are published.

What is CYCC’s weekly average amount of articles?

In an average week, 1 articles about CYCC are published.

What is CYCC’s News Sentiment?

50% of articles about CYCC were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

TAKTakeda Pharmaceutical Company

NBIXNeurocrine

AMEDAmedisys

MORFMorphic Holding

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing